However, high AR expression may be associated with endocrine resistance, as patients with ER–positive breast cancer with high ratios of AR expression to estrogen receptor (ER) expression (AR/ER) have poorer disease–free survival (DFS) [7]. Here, ESR1 is linked to breast cancer.